DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 79 filers reported holding DENALI THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,051 | +162.1% | 8,391 | +345.1% | 0.00% | – |
| Q1 2021 | $100,000 | -86.7% | 1,885 | -80.8% | 0.00% | – |
| Q4 2020 | $754,000 | +579.3% | 9,836 | +229.4% | 0.00% | – |
| Q3 2020 | $111,000 | -17.8% | 2,986 | -40.6% | 0.00% | – |
| Q2 2020 | $135,000 | +1587.5% | 5,031 | +956.9% | 0.00% | – |
| Q1 2020 | $8,000 | -92.4% | 476 | -92.1% | 0.00% | – |
| Q4 2019 | $105,000 | +43.8% | 6,023 | +25.4% | 0.00% | – |
| Q3 2019 | $73,000 | -12.0% | 4,802 | +20.4% | 0.00% | – |
| Q2 2019 | $83,000 | +538.5% | 3,990 | +515.7% | 0.00% | – |
| Q4 2018 | $13,000 | +85.7% | 648 | +105.7% | 0.00% | – |
| Q3 2018 | $7,000 | +250.0% | 315 | +162.5% | 0.00% | – |
| Q2 2018 | $2,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |